相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CSF p-tau increase in response to Aβ-type and Danish-type cerebral amyloidosis and in the absence of neurofibrillary tangles
Stephan A. Kaeser et al.
ACTA NEUROPATHOLOGICA (2022)
Kinetic profiling of therapeutic strategies for inhibiting the formation of amyloid oligomers
Thomas C. T. Michaels et al.
JOURNAL OF CHEMICAL PHYSICS (2022)
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study
Jasmeer P. Chhatwal et al.
LANCET NEUROLOGY (2022)
Blood-Based Alzheimer's Biomarkers
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat
Marta Querol-Vilaseca et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study
Estrella Morenas-Rodriguez et al.
LANCET NEUROLOGY (2022)
β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease
Atul Kumar et al.
NEUROLOGY (2022)
Signatures of glial activity can be detected in the CSF proteome
Timo Eninger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
ß-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease
Atul Kumar et al.
NEUROLOGY (2022)
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Charlotte E. Teunissen et al.
LANCET NEUROLOGY (2022)
Temporal Dynamics of β-Amyloid Accumulation in Aging and Alzheimer Disease
William J. Jagust et al.
NEUROLOGY (2021)
Donanemab in Early Alzheimer's Disease
Mark A. Mintun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Microglial activation and tau propagate jointly across Braak stages
Tharick A. Pascoal et al.
NATURE MEDICINE (2021)
Biomarkers for neurodegenerative diseases
Oskar Hansson
NATURE MEDICINE (2021)
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease
Stephen Salloway et al.
NATURE MEDICINE (2021)
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease
Eric McDade et al.
NATURE REVIEWS NEUROLOGY (2021)
DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput
Vadim Demichev et al.
NATURE METHODS (2020)
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials
Alette M. Wessels et al.
JAMA NEUROLOGY (2020)
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET
Renaud La Joie et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Neurofilaments: neurobiological foundations for biomarker applications
Arie R. Gafson et al.
BRAIN (2020)
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease
Nicolas R. Barthelemy et al.
NATURE MEDICINE (2020)
Proteopathic Seed Amplification Assays for Neurodegenerative Disorders
Natalia do Carmo Ferreira et al.
CLINICS IN LABORATORY MEDICINE (2020)
Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease
Joseph W. Lewcock et al.
NEURON (2020)
The API Generation program: Biomarker phenotyping of cognitively unimpaired participants screened in Generation study 1 and Generation study 2
Marie‐Laure Rouzade‐Dominguez et al.
Alzheimers & Dementia (2020)
Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life
Ruth E. Uhlmann et al.
NATURE NEUROSCIENCE (2020)
Aβ and tau prion-like activities decline with longevity in the Alzheimer's disease human brain
Atsushi Aoyagi et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Early Aβ reduction prevents progression of cerebral amyloid angiopathy
Juliane Schelle et al.
ANNALS OF NEUROLOGY (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
Sebastian Palmqvist et al.
EMBO MOLECULAR MEDICINE (2019)
The β-secretase (BACE) inhibitor NB-360 in preclinical models: From amyloid-β reduction to downstream disease-relevant effects
Ulf Neumann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Oliver Preische et al.
NATURE MEDICINE (2019)
The PRIDE database and related tools and resources in 2019: improving support for quantification data
Yasset Perez-Riverol et al.
NUCLEIC ACIDS RESEARCH (2019)
Amyloid-beta plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
Zhuohao He et al.
NATURE MEDICINE (2018)
Secondary nucleation in amyloid formation
Mattias Tornquist et al.
CHEMICAL COMMUNICATIONS (2018)
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
Brian A. Gordon et al.
LANCET NEUROLOGY (2018)
Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
Victor L. Villemagne et al.
NATURE REVIEWS NEUROLOGY (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
Mathias Jucker et al.
NATURE NEUROSCIENCE (2018)
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease
Eric McDade et al.
NEUROLOGY (2018)
Alzheimer's disease: The right drug, the right time Lessons from failed clinical trials can improve the development of Alzheimer's disease-modifying therapies
Todd E. Golde et al.
SCIENCE (2018)
Stop Alzheimer's before it starts
Eric McDade et al.
NATURE (2017)
Aβ seeding potency peaks in the early stages of cerebral β-amyloidosis
Lan Ye et al.
EMBO REPORTS (2017)
Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition
Juliane Schelle et al.
ALZHEIMERS & DEMENTIA (2017)
Seizure protein 6 and its homolog seizure 6-like protein are physiological substrates of BACE1 in neurons
Martina Pigoni et al.
MOLECULAR NEURODEGENERATION (2016)
Mammalian prions and their wider relevance in neurodegenerative diseases
John Collinge
NATURE (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
Mehtap Bacioglu et al.
NEURON (2016)
Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice
Deepak R. Thakker et al.
JOURNAL OF NEUROSCIENCE (2015)
A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
Ulf Neumann et al.
MOLECULAR NEURODEGENERATION (2015)
Persistence of Aβ seeds in APP null mouse brain
Lan Ye et al.
NATURE NEUROSCIENCE (2015)
Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease
Ajeet Rijal Upadhaya et al.
BRAIN (2014)
Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked
Malin K. Sandberg et al.
NATURE COMMUNICATIONS (2014)
In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques
Steffen Burgold et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Evidence for Age-Dependent in Vivo Conformational Rearrangement within Aβ Amyloid Deposits
Sofie Nystrom et al.
ACS CHEMICAL BIOLOGY (2013)
Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease
Henrik Zetterberg et al.
ALZHEIMERS & DEMENTIA (2013)
Amyloid-Beta Oligomerization in Alzheimer Dementia versus High-Pathology Controls
Thomas J. Esparza et al.
ANNALS OF NEUROLOGY (2013)
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Mathias Jucker et al.
NATURE (2013)
Changes in Amyloid-β and Tau in the Cerebrospinal Fluid of Transgenic Mice Overexpressing Amyloid Precursor Protein
Luis F. Maia et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The Metalloprotease Meprin β Generates Amino Terminal-truncated Amyloid β Peptide Species
Jessica Bien et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Prion propagation and toxicity in vivo occur in two distinct mechanistic phases
Malin K. Sandberg et al.
NATURE (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-Amyloidosis
Yvonne S. Eisele et al.
SCIENCE (2010)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Rebecca Radde et al.
EMBO REPORTS (2006)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
分享论文
